OverviewChartNewsTraderScreen

BVT Call 220 AMGN 21.06.2024/  DE000VU9Q6Z5  /

Frankfurt Zert./VONT
2024-05-14  10:33:10 AM Chg.+0.130 Bid10:59:06 AM Ask10:59:06 AM Underlying Strike price Expiration date Option type
8.250EUR +1.60% 8.230
Bid Size: 700		 8.470
Ask Size: 700		 Amgen Inc 220.00 USD 2024-06-21 Call
GlobeNewswire 9:00 AM Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 05-13 TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-09 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 05-09 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
TeleTrader 05-08 US closes flat to higher with more earnings on the horizon
GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
TeleTrader 05-03 US closes higher after softer-than-expected jobs print
TeleTrader 05-03 Wall Street surges on open as jobs report sparks rate cut hopes
TeleTrader 05-03 Amgen soars 14% on positive weight-loss drug data
TeleTrader 05-02 Amgen Q1 revenue jumps 22% to $7.4 billion
TeleTrader 05-02 US surges at close as traders weigh Fed remarks
TeleTrader 05-02 US opens higher, Dow jumps 240 points
GlobeNewswire 05-02 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 05-02 US higher premarket after Fed's decision
GlobeNewswire 05-01 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 04-30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
TeleTrader 04-24 Wall Street opens mostly higher amid earnings jitters
GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire 04-16 Turnstone Biologics Appoints William Waddill to its Board of Directors
GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness